Dynavax (DVAX) Reports Q3 Loss of $0.24/sh

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.24), versus ($0.15) reported last year. Revenue for the quarter came in at $108.3 million, versus $13.41 million reported last year.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance